Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10p -1.18% 8.35p 8.30p 8.40p 8.45p 8.15p 8.45p 764,868 14:32:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.9 -1.3 - 8.47

N4 Pharma Share Discussion Threads

Showing 5551 to 5571 of 5575 messages
Chat Pages: 223  222  221  220  219  218  217  216  215  214  213  212  Older
DateSubjectAuthorDiscuss
15/2/2019
14:00
We are in the bottom of the previous accumulation range currently. Im topping up little bits here. Have some 7p buys set too.https://twitter.com/Unic0rnCharts/status/1094648649563471879?s=19
mypanic
15/2/2019
13:56
I can see that there is money to be made trading this as its volatile. Question is, what point to enter. Risky as could be stuck with worthless stock.
jimbobaroony
15/2/2019
13:35
I see it’s all going swimmingly post the fund raising! Yes I know hugh, you have inside information that 20 deals are about to be signed and beloved Nigel thinks everything is going wonderfully well.....but strangely it appears the market doesn’t believe you! Shocking really as you are so well informed 😉...
nobbygnome
14/2/2019
14:45
10k max now at 8.3p
dave4545
14/2/2019
14:43
Lets be realistic, before the placing people were jumping over each other to pay 13-14p It's a lot better value now at 8.3p but as you say it's also been below 5p too last year
dave4545
14/2/2019
14:42
50k max from 250k
dave4545
14/2/2019
13:58
Well you're a braver man than me! Has made a nice recovery from below 5p to the current 9.5p. Let's hope N4 doesn't continue to drift down and eat into your profits.
dplewis1
14/2/2019
13:39
Back onboard at 8.3p.......bought MTFB at 6p this morning after dplewis1 post sold at 9p.............having a punt here with the profit Thanks dplewis1 for the heads up....
thaiflyer1
14/2/2019
13:15
Can buy 250k online at 8.364p Considering the placing was only a few days ago at 10p are the placing Vendors taking a loss on the stock they did not shift ?
dave4545
14/2/2019
07:13
Prime example over at MTFB this morning. Negative response from the FDA on their drug and all of a sudden they are staring down the barrel. The dangers of binary bets laid bare unfortunately for those holders.
dplewis1
13/2/2019
23:32
Fully agree, still fairly early days and although results to date are promising we have to be prepared it could go sour, hence the risk is comparible with the reward if successful. I love the concept, the business model and to some extent the handling of the generics division. I will stay invested if the results from Adelaide come back positive but unfortunately will have to move on if the efficacy of the cytolytic vaccine isn’t improved when using Nuvec. To me this test is much more important than the a Medlmmune decision.
featherby81
13/2/2019
23:21
All very interesting and let’s hope everything goes smoothly. But we are a long way off having a viable product. Remember Slidanfil! That failure can’t be ignored.
jimbobaroony
13/2/2019
23:14
Small piece from the June 17 RNS, just to clear up any confusion that may occur. Animals were dosed once with 50, 150, 400 or 900 mg/kg nanoparticles, and then observed for 14 days. Clinical observations, body weights and food consumption were recorded, blood plasma samples were analysed for clinical pathology and selected common target organs were examined microscopically. The nanoparticles did not cause any systemic toxicity and all organs examined microscopically were normal, including at the highest dose, which is likely to be many times in excess of the concentrations that might be administered to humans. While there was some mild to moderate inflammation observed at the injection sites at all doses, these were non-specific and generally indicative of local inflammation. According to the board certified pathologist used in the study, these were similar to that which would be expected following implantation of a medical device or as a result of injecting a vaccine and would almost certainly resolve over time. In conclusion, a single subcutaneous administration of the nuvec® nanoparticles to rats did not cause any toxicological effects considered likely to be of long term concern.
featherby81
13/2/2019
21:56
Nobbygnome, pure speculation and scare mongering. Look at what we know and what is probable and the picture is substantially brighter than you would have people believe. As I said before, time will tell and there should be no shortage of news and updates from N4 this year.
tankerton
13/2/2019
20:24
As I said, zero credibility. His ‘inside information’ before resulted in a massive decline in the share price when the inevitable failure arrived. To make one mistake is understandable... to make exactly the same mistake again is madness..... The company is now a one trick pony and therefore, at high risk of complete failure. Just say some adverse reaction is seen to the particles in an animal model; then it would be all over bar the shouting (probably from hugh 😆)!
nobbygnome
13/2/2019
20:00
What we do now know is that N4 will be more in the public domain as a result of Allan Heys speech at the Bionow conference today. Looking forward to feedback.
tankerton
13/2/2019
19:37
You're talking to yourself you complete lunatic! Possibly one of the funniest things I've ever seen on a share chat though to be fair.
dplewis1
13/2/2019
19:16
Oh and by the way:- dplewis113 Feb '19 - 18:53 - 1682 of 1683 (Filtered)
hughwilson
13/2/2019
18:53
Yup.. he's been saying the same twaddle about japan since last Feb. This from the 23rd: "Today is N4P's last day in Japan. I don't envisage Nigel coming back empty handed so we are looking probably at a number of news releases over the next few minutes/days/weeks." This time next year Rodney..
dplewis1
13/2/2019
18:46
I’ll give him credit, he’s persistent..
featherby81
13/2/2019
18:41
As for evidence, read the RNS`s or the Allenby report. N4 intend to sign a production agreement this year.
tankerton
Chat Pages: 223  222  221  220  219  218  217  216  215  214  213  212  Older
Your Recent History
LSE
N4P
N4 Pharma
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190217 22:40:11